This case is reserved for use by Columbia Business School Faculty only.
How can a partnership between a drug sponsor and a development partner improve the efficiency of bringing a product to market?
How can a partnership between a drug sponsor and a development partner improve the efficiency of bringing a product to market?
R-Pharm is a vertically integrated pharmaceutical firm based in Russia, serving established and emerging markets. QuintilesIMS is a transnational CRO that began as a biostatistical consulting company serving the pharmaceutical industry that has expanded into data management and monitoring of clinical trials. This case tells the story of the partnership between these two companies that brought the drug olokizumab to market efficiently and successfully.